Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
February 8, 2021 | Publications
February 8, 2021 | Publications
VBI Vaccines to Present at the Raymond James 42nd Annual Institutional Investors Conference
VBI Vaccines Announces Progress of Coronavirus Vaccine Program